Kristi Anseth, University of Colorado
Kristi Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering and Associate Faculty Director of the BioFrontiers Institute at the University of Colorado at Boulder. Her research interests lie at the interface between biology and engineering where she designs new biomaterials for applications in drug delivery and regenerative medicine. Dr. Anseth’s research group has published over 300 peer-reviewed manuscripts, and she has trained more than 100 graduate students and postdoctoral associates. She is an elected member of the US National Academy of Engineering (2009), the National Academy of Medicine (2009), the National Academy of Sciences (2013), and the National Academy of Inventors (2016). She is also a dedicated teacher, who has received four University Awards related to her teaching, as well as the American Society for Engineering Education’s Curtis W. McGraw Award. Anseth is a Fellow of the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering, American Institute of Chemical Engineers, and the Materials Research Society. She serves on the editorial boards or as associate editor of Biomacromolecules, Journal of Biomedical Materials Research — Part A, Acta Biomaterialia, Progress in Materials Science, and Biotechnology & Bioengineering.
Abstract: Engineering Precision Biomaterials for Regenerative Medicine
As the demand for precision medicine continues to rise, the “one-size fits all” approach to the design of medical devices and therapies to treat specific diseases and injuries is becoming increasingly outdated. Biomaterials have significant potential for transforming precision medicine, but individual complexity of patients often necessitates integrating multiple functions into a single biomaterial to successfully tailor personalized therapies. With this increasing complexity, engineering principles based on unit operations can aid in the design of precision biomaterials for advanced regenerative medicine products. This talk will provide specific examples where biologically responsive and multifunctional biomaterials can be integrated into devices that precisely and adaptably react to a patient’s cells or specific disease condition. These concepts will be placed in the broader context of next generation medical products that focus on repairing and reconstituting injured or diseased tissue structure and function.
Professor Max Lu has been President and Vice-Chancellor of University of Surrey since April 2016. Previously he was Provost and Senior Vice-President at the University of Queensland, Australia. He has been appointed to the Boards of National Physical Laboratory, Universities UK, Leadership Council of the National Centre for Universities and Business and as Deputy Lieutenant of Surrey. He is also a patron of Transform Housing & Support.
Professor Lu lectured at Nanyang Technological University from 1991 to 1994, and had held academic and leadership positions at the University of Queensland from 1994 to 2016, rising from senior lecturer to chair professor. He founded the Australian Research Council Centre of Excellence for Functional Nanomaterials and served as its inaugural director for 8 years. He was awarded the Australian Research Council (ARC)
New lectures will be added as they become available